Vertex Pharmaceuticals Incorporated’s Pipeline Drug Approved By FDA On July 2; Analysts Still Bullish

Vertex Pharmaceuticals Incorporated excited Wall Street on July 2 after the company announced that the U.S. Food and Drug Administration (FDA) approved its pipeline drug, Orkambi.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.